Generic PrEP now available on NHS

Back to news & events

Friday 8th September 2017

NHS National Procurement has concluded a tender process for the supply of emtricitabine / tenofovir disoproxil tablets that will be used for both treatment and prevention of HIV infection in NHS Scotland.

The contract will come into effect on 1 November 2017.

Awarded Suppliers

The two (2) suppliers recommended for use in Scotland are:

  • For treatment of HIV infection - Zentiva (Emtricitabine / Tenofovir Disoproxil Phosphate)
  • For PrEP - Dr Reddy’s (Emtricitabine / Tenofovir Disoproxil Succinate)

The award of this contract has secured substantial savings for NHS Scotland.
Contract pricing is commercially sensitive and cannot be shared at this time however a document will be issued to health boards shortly with details of new prices and the available savings opportunities.

Read the statement from NHS National Procurement [PDF - 105kB]